SB 572

Adds new GS 58-3-241 (pertaining to fertility treatment coverage), as follows. Defines experimental fertility procedure, fertility treatment, and insurer. Directs that, if health benefit plan provides fertility treatment coverage then (1) any limitation on coverage for ovulation medication cannot be different than the limits imposed on other prescription medications and (2) no annual or lifetime limits may apply to the coverage for ovulation medication and in-network ovulation induction cycles. Specifies that GS 58-3-241 cannot be construed to required coverage for fertility treatment or experimental fertility procedures under a health benefit plan. Applies to insurance contracts issued, renewed or amended on or after October 1, 2025.